ZNF776 Inhibitors
Chemical inhibitors of ZNF776 can interfere with its function through several signaling pathways by targeting the enzymes that regulate phosphorylation and other cellular processes. Staurosporine, a robust protein kinase inhibitor, disrupts the activity of numerous serine/threonine kinases involved in the phosphorylation of proteins, including ZNF776. This broad-spectrum inhibition can lead to a decrease in ZNF776's phosphorylation and subsequent activity. Similarly, LY294002 and Wortmannin, both inhibitors of phosphoinositide 3-kinases (PI3K), disrupt the PI3K pathway, which can have downstream effects on the function of ZNF776. By impeding PI3K, these inhibitors can alter the signaling cascade that may modulate the activity of ZNF776. PD98059 and U0126, which selectively inhibit mitogen-activated protein kinase kinase (MEK), and SB203580, which inhibits p38 MAP kinase, can also affect the phosphorylation state and function of ZNF776 through the MAPK/ERK pathway. The inhibition of MEK and p38 MAP kinase by these chemicals can lead to reduced activity of ZNF776, as they play a role in regulating protein functions via phosphorylation.
Other inhibitors, such as SP600125, which targets c-Jun N-terminal kinase (JNK), and Y-27632, which inhibits Rho-associated protein kinase (ROCK), can disrupt additional cell signaling pathways that might influence ZNF776's function. SP600125 inhibits the JNK signaling, which can alter the activity of various proteins, including ZNF776. Y-27632's inhibition of ROCK can also lead to changes in the function of ZNF776, as ROCK is implicated in many cellular processes. Furthermore, PP2, an inhibitor of Src family tyrosine kinases, can impact ZNF776 by inhibiting Src kinases that regulate several signaling pathways. Rapamycin, an inhibitor of the mammalian target of rapamycin (mTOR), can affect ZNF776 by modulating the mTOR signaling pathway. Lastly, GF109203X and Chelerythrine, both selective inhibitors of protein kinase C (PKC), can inhibit the function of ZNF776 by targeting PKC, which is involved in signaling pathways that regulate the activity of various proteins, including ZNF776.
SEE ALSO...
Items 1 to 10 of 12 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Staurosporine | 62996-74-1 | sc-3510 sc-3510A sc-3510B | 100 µg 1 mg 5 mg | $82.00 $153.00 $396.00 | 113 | |
Staurosporine is a potent, non-selective inhibitor of protein kinases, including many serine/threonine kinases. By inhibiting these kinases, staurosporine can inhibit the phosphorylation of ZNF776, thus impairing its function. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a specific inhibitor of phosphoinositide 3-kinases (PI3K). Since PI3K can regulate a variety of cellular processes including those that may involve ZNF776, inhibition by LY294002 can disrupt signals that lead to the functional activity of ZNF776. | ||||||
PD 98059 | 167869-21-8 | sc-3532 sc-3532A | 1 mg 5 mg | $40.00 $92.00 | 212 | |
PD98059 is a selective inhibitor of mitogen-activated protein kinase kinase (MEK), which is part of the MAPK/ERK pathway. As MEK influences the phosphorylation of certain proteins, PD98059's inhibition could extend to the functional impairment of ZNF776. | ||||||
U-0126 | 109511-58-2 | sc-222395 sc-222395A | 1 mg 5 mg | $64.00 $246.00 | 136 | |
U0126 is another MEK inhibitor that impairs the MAPK/ERK signaling pathway. By inhibiting this pathway, U0126 can reduce the phosphorylation of proteins involved in this pathway, potentially including ZNF776, thereby inhibiting its function. | ||||||
SB 203580 | 152121-47-6 | sc-3533 sc-3533A | 1 mg 5 mg | $90.00 $349.00 | 284 | |
SB203580 selectively inhibits p38 MAP kinase, which could be involved in the regulation of ZNF776's function. Inhibition of p38 MAP kinase by SB203580 can therefore lead to the inhibition of ZNF776's activity. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125 is an inhibitor of c-Jun N-terminal kinase (JNK), which plays a role in cell signaling pathways that can influence the function of various proteins. Inhibition of JNK can thus inhibit the function of ZNF776. | ||||||
Y-27632, free base | 146986-50-7 | sc-3536 sc-3536A | 5 mg 50 mg | $186.00 $707.00 | 88 | |
Y-27632 is a selective inhibitor of Rho-associated protein kinase (ROCK). ROCK is part of cell signaling pathways that can impact the activity of different proteins. Inhibiting ROCK with Y-27632 can lead to the inhibition of ZNF776's function. | ||||||
PP 2 | 172889-27-9 | sc-202769 sc-202769A | 1 mg 5 mg | $94.00 $227.00 | 30 | |
PP2 is an inhibitor of Src family tyrosine kinases. Src kinases can regulate several signaling pathways that could involve ZNF776. By inhibiting Src kinases, PP2 can inhibit the functional activity of ZNF776. | ||||||
Wortmannin | 19545-26-7 | sc-3505 sc-3505A sc-3505B | 1 mg 5 mg 20 mg | $67.00 $223.00 $425.00 | 97 | |
Wortmannin is a potent and irreversible inhibitor of PI3K, similar to LY294002. By inhibiting PI3K, wortmannin can disrupt the cellular processes and signaling pathways that may involve ZNF776, leading to its functional inhibition. | ||||||
Rapamycin | 53123-88-9 | sc-3504 sc-3504A sc-3504B | 1 mg 5 mg 25 mg | $63.00 $158.00 $326.00 | 233 | |
Rapamycin inhibits the mammalian target of rapamycin (mTOR), a central regulator of cell growth and proliferation. mTOR inhibition can impact the signaling pathways and cellular processes where ZNF776 may play a role, leading to its functional inhibition. | ||||||